Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ReShape Lifesciences, Inc. - Common Stock (NQ:RSLS)

2.480 -0.010 (-0.40%)
Streaming Delayed Price Updated: 10:56 AM EDT, Aug 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 47,440
Open 2.550
Bid (Size) 2.450 (4)
Ask (Size) 2.480 (1)
Prev. Close 2.490
Today's Range 2.420 - 2.550
52wk Range 2.230 - 303.25
Shares Outstanding 712,680
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Friday's After-Market Session
 
Via Benzinga
Thursday's after hours session: top gainers and losers
After the closing bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session. 
Via Chartmill

Performance

YTD
-97.8%
-97.8%
1 Month
+4.2%
+4.2%
3 Month
-76.4%
-76.4%
6 Month
-97.2%
-97.2%
1 Year
-99.0%
-99.0%

More News

Read More
ReShape Lifesciences® Announces Partial Adjournment of Special Meeting of Stockholders
From ReShape Lifesciences Inc
Via GlobeNewswire
ReShape Lifesciences® to Host Inaugural Lap-Band® Surgeon Summit
From ReShape Lifesciences Inc
Via GlobeNewswire
ReShape Lifesciences® to Host Special Meeting of Stockholders on July 24, 2025
From ReShape Lifesciences Inc
Via GlobeNewswire
ReShape Lifesciences® Granted U.S. Patent Related to an Intragastric Balloon System
From ReShape Lifesciences Inc
Via GlobeNewswire
ReShape Lifesciences® Regains Compliance with Nasdaq Minimum Stockholders Equity Requirement
From ReShape Lifesciences Inc
Via GlobeNewswire
ReShape Lifesciences® Announces Strategic Cost Reductions and Provides Update on the Merger Agreement with Vyome Therapeutics and Asset Purchase Agreement with Biorad Medisys
From ReShape Lifesciences Inc
Via GlobeNewswire
ReShape Lifesciences® Granted Key International Patent in Australia for Its Proprietary Diabetes Neuromodulation Technology
From ReShape Lifesciences Inc
Via GlobeNewswire
Why RH Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Here are the top movers in Thursday's session.
Via Chartmill
AI & Tech Breakout: PRSO, IPA, NEHC, SOAR Lead Today’s Innovation Surge – More Movers Inside
Via AB Newswire
Topics Artificial Intelligence
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
ReShape Lifesciences Stock Soars On Distribution Agreement With Recon Supply, Draws Retail Applause
Via Stocktwits
Let's take a look at the stocks that are in motion in today's session.
Via Chartmill
There are notable gap-ups and gap-downs in today's session.
Via Chartmill
ReShape Lifesciences® Signs Exclusive Distribution Agreement with Recon Supply to Access the VA and DoD Markets
From ReShape Lifesciences Inc
Via GlobeNewswire
Which stocks are moving on Monday?
Via Chartmill
ReShape Lifesciences Stock Slumps As Company Prices Public Offering At Significant Discount: Retail Holds On To Optimism
Via Stocktwits
Crude Oil Moves Higher; Graham Shares Surge After Q4 Results
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Let's have a look at the top gainers and losers in the middle of the day of today's session.
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill
US Stocks Mixed; Motorcar Parts of America Posts Upbeat Earnings
Via Benzinga
ReShape Lifesciences® Announces Pricing of $2.6 Million Public Offering
From ReShape Lifesciences Inc
Via GlobeNewswire

Frequently Asked Questions

Is ReShape Lifesciences, Inc. - Common Stock publicly traded?
Yes, ReShape Lifesciences, Inc. - Common Stock is publicly traded.
What exchange does ReShape Lifesciences, Inc. - Common Stock trade on?
ReShape Lifesciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for ReShape Lifesciences, Inc. - Common Stock?
The ticker symbol for ReShape Lifesciences, Inc. - Common Stock is RSLS on the Nasdaq Stock Market
What is the current price of ReShape Lifesciences, Inc. - Common Stock?
The current price of ReShape Lifesciences, Inc. - Common Stock is 2.480
When was ReShape Lifesciences, Inc. - Common Stock last traded?
The last trade of ReShape Lifesciences, Inc. - Common Stock was at 08/04/25 10:56 AM ET
What is the market capitalization of ReShape Lifesciences, Inc. - Common Stock?
The market capitalization of ReShape Lifesciences, Inc. - Common Stock is 1.77M
How many shares of ReShape Lifesciences, Inc. - Common Stock are outstanding?
ReShape Lifesciences, Inc. - Common Stock has 2M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.